ÂÜÀòÂÒÂ×

Amy Johnson, PhD is Vice President of Medical Affairs of Vincerx. Before Vincerx, Dr Johnson was Senior Director of Translational Research at Janssen Oncology responsible for preclinical and biomarker research in hematological malignancies. Prior to joining industry in 2017, she had a highly productive and successful career in experimental therapeutics research at The Ohio State University, Columbus, Ohio where she was Associate Professor of Medicine with tenure. At OSU, Amy served in many roles, including Coleader of the Leukemia Research Program and Coprincipal Investigator of three R01 National Cancer Institute grants. Dr Johnson led her own laboratory and served as mentor to many undergraduate and graduate students and has contributed to more than 100 peer-reviewed publications.

Dr Johnson received her PhD in Pharmaceutical Sciences from University of Kentucky, Lexington. Amy also completed a postdoctoral fellowship in the laboratory of John Byrd, MD at OSU.